Sources: Apple held talks, that are now over without a deal, to buy Crossover Health, approached One Medical as part of push into health care
- It's not clear if Apple wanted to own and operate a network of health clinics, like its retail stores, or simply partner to sell products with a health-related angle, like the Apple Watch
Context & Ripple Effects
By late 2017 Apple had already spent months wiring the iPhone into the medical system — talks with the Argonaut Project and Carin Alliance to make it a medical records hub, and work with Health Gorilla to pull lab results onto the device. The Crossover Health talks and the approach to One Medical show the next step under consideration was physical: owning or operating clinics outright, with the open question being whether Apple wanted a retail-store-style network or just a health-flavored sales channel.
The talks ended without a deal, and the arc that follows is telling: Apple launched AC Wellness, its own employee-only clinic group, five months later — a scaled-down version of the acquisition path — before reports of stalled projects, staff departures from the health unit, and a 2023 retrospective on how conservatism and internal disagreement blunted the ambition.
First-order effects
- Crossover Health and One Medical both stay independent of Apple, leaving each free to sell employer-clinic services to other large companies while remaining candidates for future deals.
Second-order effects
- Denied an owned network, Apple builds one in miniature instead — AC Wellness serves only employees and families, which keeps the clinic experiment contained but limits the data and scale a full acquisition would have delivered.
Third-order effects
- If the pattern holds, big-tech healthcare entry runs through employer clinics and device-side data hubs rather than hospital-scale ownership — a structure that later coverage of departures and stalled pilots suggests is harder to sustain internally than to buy.
The trend: Tech companies entering healthcare are cycling between acquiring clinic operators and building constrained in-house versions, with Apple's employee-clinic compromise marking the retreat from full ownership.